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Abstract
Transitions between consecutive phases of the eukaryotic cell cycle are driven by the catalytic activity of selected sets of
cyclin-dependent kinases (Cdks). Yet, their occurrence and precise timing is tightly scheduled by a variety of means
including Cdk association with inhibitory/adaptor proteins (CKIs). Here we focus on the regulation of G1-phase duration by
the end of which cells of multicelled organisms must decide whether to enter S phase or halt, and eventually then,
differentiate, senesce or die to obey the homeostatic rules of their host. In mammalian cells, entry in and progression
through G1 phase involve sequential phosphorylation and inactivation of the retinoblastoma Rb proteins, first, by cyclin D-
Cdk4,6 with the help of CKIs of the Cip/Kip family and, next, by the cyclin E-Cdk2 complexes that are negatively regulated by
Cip/Kip proteins. Using a dynamical modeling approach, we show that the very way how the Rb and Cip/Kip regulatory
modules interact differentially with cyclin D-Cdk4,6 and cyclin E-Cdk2 provides to mammalian cells a powerful means to
achieve an exquisitely-sensitive control of G1-phase duration and fully reversible G1 arrests. Consistently, corruption of
either one of these two modules precludes G1 phase elongation and is able to convert G1 arrests from reversible to
irreversible. This study unveils fundamental design principles of mammalian G1-phase regulation that are likely to confer to
mammalian cells the ability to faithfully control the occurrence and timing of their division process in various conditions.
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Introduction
Living systems are born to reproduce and the most important
challenge individual cells are faced with in their life is to decide
whether and when it is time to divide. This decision is usually
made during G1 phase (the lag phase that separates mitosis from
the initiation of DNA replication) of the cell-division cycle, shortly
before S-phase entry, at a specific ‘Start’ point in budding yeast
[1], called restriction (R) point in animal cells [2], beyond which
cells are irrevocably committed to divide independently of
exogenous cues. While S-phase entry relies on the abrupt
accumulation of active cyclin E-Cdk2 complexes in the nucleus,
eukaryotic cells have evolved two major mechanisms to delay and
prevent G1/S transit [3]: (i) downregulation of cyclin synthesis; (ii)
inhibition of the cyclin E-Cdk2 activity by association with Cdk
inhibitory proteins (CKIs). The first mechanism, which primarily
operates in response to growth-factor withdrawal, induces a
reversible quiescent (G0)-like phenotype. The second one, which is
activated in response to a wide diversity of endogenous and
exogenous signals, delays progression through G1 phase and may
lead to reversible or irreversible G1 arrest (Fig. 1A). CKIs that
share the same ability to enforce G1-phase delay or arrest in
response to stress and differentiation signals are present in most, if
not all, eukaryotic cells even though their primary structure may
widely diverge amongst species [4–8].
In multicellular organisms like mammals, cell division actively
takes place during development and tissue regeneration. This is no
longer true, however, in most fully-developed organs in which
local and systemic controls restrain cell division in order to
maintain tissue homeostasis and prevent the emergence of cancer
[9,10]. There is clear evidence that interaction between the two
G1-specific activatory modules, cyclin D-Cdk4,6 and cyclin E-
Cdk2, and CKIs plays a paramount role in mammalian G1-phase
control. It is still obscure, however, what particular features of this
interaction might enable mammalian cells to precisely control in a
contextual manner the length of their G1 phase [11,12] and,
ultimately, make the right decision regarding the occurrence of
one amongst its many possible outcomes, i.e. cell division,
differentiation, senescence or death [13]. The mammalian G1
regulatory network presents two striking designs that, conceivably,
could participate in these events. First, cyclin D-Cdk4,6 and cyclin
E-Cdk2 are activated sequentially during G1-phase progression
owing to the fact that cyclin E transcription is repressed by
unphosphorylated Rb proteins via the mobilization of chromatin-
modifying factors and is relieved following partial Rb phosphor-
ylation by cyclin D-Cdk4,6 [14,15]. Second, CKIs of the Cip/Kip
family that accumulate in response to stress or differentiation
signals exert an opposite effect on cyclin D-Cdk4,6 and cyclin E-
Cdk2 as they facilitate the activity of the former complexes while
they inhibit the activity of the latter ones [16–18]. In this paper, we
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organization of the mammalian G1 regulatory network determine
the rate of G1-phase progression and shape the properties of G1
arrest? More generally, are there specific decision-making
strategies encoded at the level of this sophisticated molecular
network organization?
To answer these issues, we used a modeling approach that has
proved useful to unveil design principles of molecular networks,
especially those involved in cell-cycle regulation [19]. Yet, because
our interest was more specifically focusing on the G1-phase period,
a model of the whole cell cycle was not necessarily of use [20,21].
That is why, we built and analysed a molecular network model
limited to the cell-cycle period going from G0 exit to S-phase entry
[22–26]. A major improvement of our model on previous ones in
the field lies in the fact that it incorporates some detailed features
of the interaction between the G1-specific cyclin-Cdks and the
Rb/E2F and Cip/Kip regulatory modules. The model does not
only reproduce the typical, previously-described properties of G1/
S transition, including discreetness and irreversibility, but it also
reveals how stockpiling of the Cip/Kip proteins in response to
stress signals impinges on G1-phase progression such as to endow
mammalian cells with the ability to easily adjust the length of their
G1 phase and sustain a reversible G1 arrest. Consistently, we
found that reducing the selectivity of inhibitory controls over
cyclin D-Cdk4,6 and cyclin E-Cdk2 precludes long-lasting G1
phases and converts the reversible G1 arrests into irreversible ones.
We further stress that these poles apart types of cell-cycle arrest
correspond to two qualitatively distinct decision-making scenarios
in terms of dynamical system theory [27].
Results
A core model of the mammalian G1-phase regulatory
network
The eukaryotic cell-cycle machinery. Eukaryotic cell cycle
progression basically relies on a tight competition between two
major players: cell-cycle activators and inhibitors. The model
interaction graph shown in Figure 1B incorporates the main
positive and negative regulators of G1 phase. Among cell-cycle
activators are the cyclins D and E together with their Cdk4,6 and
Cdk2 partners, respectively, and one subfamily of transcriptional
factors termed activator E2Fs, which stimulate the transcription of
genes involved in both cell division, notably cyclin E, and cell
death [28]. The cell-cycle inhibitors included in our model are the
members of the retinoblastoma (Rb) protein family that bind to
and inhibit the activator E2Fs and the members of the Cip/Kip
family of CKIs (p21Cip1, p27Kip1, p57Kip2).
Activatory and inhibitory G1-phase regulatory
signals. Synthesis and accumulation of cell-cycle activators and
inhibitors require the activation of two distinct types of pathways : (i)
on the one hand, the continuous provisioning of growth factors (that
is pooled into the controlparameter IGF, where the GF index stands
for growth factors) facilitates cyclin D synthesis and accumulation
andtheformation, activation andnuclearaccumulationof cyclinD-
Cdk4,6 complexes; (ii) on the other hand, genotoxic and cytotoxic
stresses (e.g. DNA damage, depletion of nucleotide triphosphates,
hypoxia, nutrient deprivation, cell-cell contact, oncogenic signals,
cell deformation, …) as well as differentiation signals (that are
pooled into the control parameter ISF, where the SF index stands
for stress factors) facilitate the accumulation of CKIs. The present
model does not take into account the influence of cell size and cell
growth although cyclin-Cdks have been acknowledged both to
regulate and beregulatedbycellgrowth[29–31].Thisisbecausewe
are interested here in understanding the behaviour of cells from
multicelled species in which G1-phase progression is not limited by
cell growth but rather by exogenous and endogenous stress signals
[9].
Selective interactions between Rb proteins and G1-
specific cyclin-Cdks complexes. Exit from G0 in
mammalian cells is contingent upon growth factor-induced
accumulation of cyclin D-Cdk4,6 whose first mission is to
initiate Rb phosphorylation and, thereby, relieve the
transcriptional repression of cyclin E genes by the Rb-E2F
complexes [14]. Then, besides initiating the assembly and
activation of replication complexes [32], the emerging cyclin E-
Cdk2 complexes play a critical role, consisting in phosphorylating
the Rb proteins whereby they free the activator E2Fs that activate
a cohort of cell cycle-regulating genes and promote G1/S transit.
Rb proteins, thus, can exist under three different phosphorylated
forms, each of which exerts unique activities [15,33,34] : (1)
unphosphorylated, they act as transcriptional repressors by
inhibiting the activity of all three RNA polymerases [35], but
also by selectively inhibiting the transcription of a number of
genes, including cyclin E but not cyclin D, via the mobilization of
chromatin-modifying factors [36]; (2) when partially
(hypo)phosphorylated by cyclin D-Cdks, they lose their ability to
directly repress transcription, including that of cyclin E; (3) when
hyperphosphorylated by cyclin E-Cdk2, they dissociate from the
Figure 1. CKI-dependent regulation of mammalian G1-phase progression. (A) Cells leaving G0 following growth-factor stimulation (IGF)
and exposed to stress/differentiation signals (ISF) during G1 phase may be driven towards either one of two alternative fates: either G1-phase
elongation or G1-arrest, which can be reversible or irreversible. (B) G1-phase progression in the presence of both IGF and ISF signals relies on a tight
competition between two major players: IGF-induced cell-cycle activators and ISF-induced cell-cycle inhibitors. Main positive regulators (Grey
ellipses) are the G1-specific, D- and E-type cyclins together with their favorite CDK partners and one subfamily of transcriptional factors termed
activator E2Fs, which ultimately trigger S-phase entry. Negative regulators (White ellipses) include the unphosphorylated and hypophosphorylated
Rb proteins and the members of the Cip/Kip family of CKIs (p21Cip1, p27Kip1, p57Kip2). Note that cyclin D-Cdks and cyclin E-Cdks are differentially
regulated by unphosphorylated Rb and Cip/Kip proteins (see asterisks).
doi:10.1371/journal.pone.0035291.g001
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involved in both cell division and cell death, of which cyclin E.
Selective interactions between Cip/Kip proteins and G1-
specific cyclin-Cdks. Cell-cycle arrest in G1 phase is mediated
in great part by the p21/p27 members of the Cip/Kip family of
CKIs, which bind to and inhibit the activity of all cyclin-Cdk1,2
complexes. The Cip/Kip proteins, in turn, are quickly
downregulated upon phosphorylation by the cyclin-Cdk1,2
complexes, which indicates a strong mutually-antagonistic
interaction between these two components. The interaction
between Cip/Kip proteins and cyclin D-Cdk is more versatile
and subject to controversy. On the one hand, Cip/Kip proteins
bind to the cyclin D-Cdk complexes that they assemble and target
to the nucleus without inhibiting their kinase activity [16,17]. On
the other hand, it has been reported recently that context-
dependent tyrosine-dephosphorylation of p27Kip1 can turn their
activatory role into an inhibitory one [37,38]. In our standard
model of G1-phase, Cip/Kip will be considered as an activator of
cyclin D-Cdk although the alternative scenario will be also
investigated upon modification of the model.
Cip/Kip-mediated inhibition of cyclin E-Cdk2 delays S-
phase entry and induces G1 arrest
For the sake of simplification, it is convenient to consider that
G1-phase progression relies on the contrasting activity of only two
families of signals: (i) activatory signals, which promote cell division
initially by facilitating the accumulation of cyclin D-Cdk4,6 and (ii)
inhibitory signals, which oppose cell division by facilitating the
accumulation of Cip/Kip proteins. In this case, indeed, the rate of
G1-phase is expected to critically depend on the relative levels of
the two competing signals. Figure 2 recapitulates how the
combination of cell-cycle activatory and inhibitory signals may
not only determine the outcome of G1-phase progression but also
the timing of G1-phase events. We performed numerical
calculations to simulate how G1 phase proceeds in response to a
simultaneous step of growth factors and of stress factors applied at
time ti. S-phase entry is assumed to occur at time ts, when the
concentration of the activator E2Fs becomes larger than half its
maximum value. Consistently with previous modeling studies and
bifurcation analysis (Fig. S1A), G1/S transition is triggered via a
bistable switching process. In this case, bistability is primarily
generated by a positive feedback loop through which cyclin E-
Cdk2 free the E2F factors from Rb proteins and, thereby, boost
cyclin E synthesis and their own accumulation, though other
positive feedback loops could possibly also participate in this
process [21,26]. Therefore, G1-phase duration can be defined as
the time gap tG1~ts{ti.
Figure 2A depicts the way how the rate of G1-phase progression
(1=tG1) varies as a function of IGF and ISF. Expectedly, irreversible
S-phase entry requires high enough IGF level and low enough ISF
level. Yet, the rate of G1-phase progression does not evolve in the
same way as a function of IGF and of ISF : 1=tG1 gradually falls
when IGF decreases, whereas it first remains nearly constant and,
then, slowly decreases when ISF increases. As illustrated in
Figure 2B, four main scenarios of G1-phase progression can thus
be outlined depending on the relative strengths of the IGF and ISF
signals. First, below a given IGF threshold, the network activity
remains in a G0-like state, in which Rb proteins are unpho-
sphorylated and the activities of both cyclin E-Cdk2 and E2Fs are
low (Fig. 2Ba). Above this threshold, the outcome of G1-phase
progression critically depends on the ISF level. At low enough ISF
signal, G1-phase progression quickly drifts toward a S-phase entry
state associated with a sharp rise in the activities of cyclin E-Cdk2
and E2Fs. Within this scenario, sequential Rb phosphorylation
does not occur because the Rb proteins, which are rapidly
hyperphosphorylated by cyclin E-Cdk2, fail to accumulate in their
hypophosphorylated form (Fig. 2Bb). At higher ISF signal, the
Cip/Kip proteins accumulate up to a level that becomes sufficient
to inhibit the cyclin E-Cdk2 activity without compromising exit
from G0, thus enabling sequential Rb phosphorylation to
effectively occur and, hence, the accumulation of hypopho-
sphorylated Rb proteins that is required to delay G1 phase
progression (Fig. 2Bc). Further ISF increase above a critical ICz
value prevents Rb hyperphosphorylation, thereby blocking S-
phase entry (Fig. 2Bd) and setting a stable G1-arrest state in which
Rb proteins are steadily hypophosphorylated and the activities of
both cyclin E-Cdk2 and E2Fs are kept at relatively low levels.
These simulations bring to the fore that, within the G1
regulatory scheme depicted in Figure 1, Cip/Kip protein
stockpiling is instrumental to favor accumulation of hypopho-
sphorylated Rb proteins over that of hyperphosphorylated Rb
proteins and, thus, endow mammalian cells with the ability to
easily adjust their G1-phase length.
Identification of regulatory features that contribute to
tunable G1 length and reversible G1 arrest
In the previous section, we have shown that stress signal-
dependent acccumulation of Cip/Kip proteins can delay S-phase
entry and eventually induce a stable G1-arrest state when the ISF
intensity reaches a critical level, ICz. In order to assess whether
this cell-cycle arrest is reversible, we performed numerical
calculations to simulate how the G1-arrest state evolves when
the ISF signal is gradually removed. We found that G1-phase
progression is restored as soon as ISF falls below a critical value
IC{ equal to ICz, hinting that the G1-arrest state is fully
reversible (Fig. 3A).
It was reasonable to hypothesize that the reversible nature of
mammalian G1 arrest takes root in the underlying mechanisms of
G1-phase regulation, notably in the intricate relationship between
the two G1-specific activatory modules and CKIs of the Cip/Kip
family. Remind that G1-phase progression is governed by the
sequential activation of cyclin D-Cdk4,6 and cyclin E-Cdk2 and
that CKIs of the Cip/Kip family exert an opposite effect on cyclin
D-Cdk4,6 and cyclin E-Cdk2. In order to test this hypothesis, we
performed numerical calculations to simulate how G1-phase
duration depends on ISF and evaluated IC{ and ICz in two
distinct hypothetical situations, in which: (1) Cip/Kip proteins
inhibit the kinase activity of cyclin D-Cdks (Fig. 3B); (2) cyclin E
transcription is not selectively repressed by unphosphorylated Rb
(Fig. 3C). In the first situation, the plot depicting the rate of G1-
phase progression (1=tG1) as a function of ISF shows that 1=tG1
sharply decreases when ISF becomes close to ICz. Moreover, G1-
phase progression is restored upon stress removal when ISF falls
below a critical value IC{vICz, indicating that the G1-arrest
state cannot be reversed for ISF values comprised between IC{
and ICz. In the second situation, 1=tG1 drops even faster when
ISF gets close to ICz and the ISF window in which irreversible G1
arrest occurs is still broader (Fig. 3C).
Besides the identification of strategic G1-phase regulatory
features, the result of Fig. 3 underscores the existence of two
poles apart decision-making scenarios according to whether
ICz{IC{
ICz
is null (i.e., reversible case) or positive (i.e., irreversible
case). To trace back the origin and the significance of these
qualitative differences, we also perform bifurcation and sensitivity
analysis for the standard and modified G1-phase models (see
section A of Text S1). One the one hand, standard bifurcation
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ible scenarios since bifurcation diagrams are qualitatively similar
(compare Fig. S1A and B). On the other hand, sensitivity analysis
allows to check that the singular relationship between G1-phase
design and decision-making properties does not depend on the
precise value of model parameters. Figure S2 shows that
ICz{IC{
ICz
remains either null for the standard G1-phase model
or strictly positive for the modified models despite variations of
model parameters of about 30% that leads to significant variations
of ICz and IC{ threshold values.
Dynamical analysis of distinct mechanisms of G1-phase
decision
The dynamical origin of the qualitative differences in G1 length
tunability and G1-arrest reversibility unveiled in Figure 3 becomes
apparent if one plots schematically the trajectory of G1-phase
progression on an appropriate projection of the protein concen-
tration space (Fig. 4). In normal proliferation conditions, the
concentrations of the cell-cycle regulatory proteins evolve with
time along a limit-cycle trajectory in the high-dimensional protein
concentration space, more specifically on the G1-phase portion of
a such closed orbit trajectory in our study. Accumulation of Cip/
Kip proteins during G1 phase modifies the attractor landscape
until, at a critical level of ISF signal, a stable G1-arrest state
emerges, typically through a saddle-node bifurcation. Depending
on the G1-phase regulatory scheme, however, a stable G1-arrest
state can emerge either along or apart from the trajectory of G1-
phase progression. Accordingly, the critical level of ISF signal,
ICz, at which the cell-cycle trajectory arising from a mitotic or
G0-arrest state converges to a G1-arrest state, may be equal to or
larger than the critical level of ISF signal, IC{, at which the G1-
arrest state is stabilized or destabilized. Extrapolating to the full
cell cycle, these two examples of cell-cycle exit would correspond
to two distinct bifurcation scenarios of limit cycles [27]: (i) a saddle-
node bifurcation would occur on an invariant circle (called SNIC
bifurcation) when ICz~IC{; (ii) a saddle homoclinic bifurcation
would occur at ICz when ICzwIC{.
In these two distinct decision-making scenarios, the relationship
between G1 length and ISF can be captured analytically when the
G1 length diverges for ISF approaching ICz (see section B of Text
S1):
1=tG1!
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ICz{ISF
p
ð1Þ
1=tG1!1=ln½a(ICz{ISF) ð 2Þ
according to whether the dynamical trajectory associated with G1-
phase progression passes near a saddle-node ghost (Eq. 1) or near a
saddle equilibrium (Eq. 2). These asymptotic laws for G1 length
tunability are indeed observed for the standard model and the
modified ones when fitting the curves of Figure 3 on a log-log plot
(Fig. S3).
Noisy decision times versus noisy decision fates
Our study thus unveils how subtle differences in the organisa-
tion of the G1 regulatory network may nevertheless change
drastically the property of G1-phase progression, especially
whether G1-arrest state is reversible or irreversible like during
senescent or terminally-differentiated state. We show in Figure 5
that cell populations subjected to noisy ISF signals statistically
behave quite differently depending on the G1-regulatory scheme
and G1-arrest strategy that prevail in individual cells. We
simulated G1-phase progression in cells subjected to different
temporal patterns of ISF signal characterized nevertheless by the
same mean and variance. We then measured the standard
deviation sfate of the decision fates and the standard deviations
stG1 of the decision times, which are defined as followed:
sfate~½
X
D2
i {(
X
Di)
2 
1=2 ð3Þ
stG1~½
X
(tG1)
2
i {(
X
(tG1)i)
2 
1=2 ð4Þ
where the D value is equal to 1, if the final outcome is to enter S-
phase, and 0, otherwise. For cells displaying the regulation scheme
depicted in Figure 3A, all cells are likely to experience the same
fate (except in a very small window), either S-phase entry or G1-
phase arrest depending on the mean value of ISF (left panel of
Fig. 5A). Yet, when they progress towards S-phase entry, they do
Figure 2. Rate-limiting factors for G1/S transit. (A) Plot depicting the evolution of the rate of G1-phase progression (1=tG1) as a function of IGF
and ISF for a simultaneous step of IGF and ISF signals. (B) Time-dependent changes in normalized concentration of the main G1 regulatory
components following cell exposure to a simultaneous step of IGF and ISF signals at time ti. Before that time, IGF~ISF~0 and the cell stands in a
G0-like state. Entry into S phase is assessed by the sharp rise of E2F at time ts. G1-phase duration is defined as the time gap tG1~ts{ti. Four
combinations of signal intensities are considered: (a) IGF~0:1, ISF~0:1; (b) IGF~0:6, ISF~0:1; (c) IGF~0:6, ISF~0:2; (d) IGF~0:6, ISF~0:5.
According to the terminology in Table 1, the concentrations shown are: ½Rb z½Rb:E2F  (dashed line), ½Rbp z½Rbp:E2F  (dotted line), ½E:I z½D:I 
(dash-dotted line), ½E2F  (full line).
doi:10.1371/journal.pone.0035291.g002
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Contrastingly, in the situation corresponding to the regulation
scheme combining those depicted in Figure 3B and C, cells are
prone to experience different fates for a broad range of vISFw
(right panel of Fig. 5A) and those which progress towards S-phase
entry tends to display a G1 phase of equal length as assessed by the
low stG1 value and the temporal profile of Cip/Kip proteins in
various cells (right panels of Figs. 5B and C). It is worth to mention
that similar results are obtained by considering intrinsic molecular
noises instead of noises in input signals. Thus, fluctuations,
extrinsic or intrinsic, can produce either noisy decision times or
rather noisy decision fates depending on the particular G1-phase
regulatory scheme. Our result suggests that the G1-phase
organization of mammalian cells (left panels of Fig. 5) would
favor fate reliability over fast decisions, which makes sense since
cells in multicellular organisms are exempt from the imperative to
divide rapidly and must avoid inappropriate decisions that may
perturb the homeostasis of their host as in tumorigenesis.
Discussion
Design features of mammalian G1-phase flexibility
Whereas the core cell division process is strongly conserved
amongst eukaryotes, entry in and progression through G1 phase
follow a highly changeable course depending on cell type and
environmental cues. In that phase, mammalian cells are
submerged with an abundance of conflicting signals, competing
with each other to encourage cell fates as irreconcilable as cell
division, differentiation, senescence and death [9,13]. In that
phase also, like in G2, cells are required to repair DNA damages
and replication errors committed in S phase. It is not astonishing
therefore that mammalian cells have evolved an exceedingly
complex web of molecular interactions to control in a contextual
Table 1. Model equations and parameters.
Differential equations
d½GF =dt~sGFIGF=(kGFzIGF){dGF½GF 
d½Rb =dt~sRb{k1zk6zdE2F½Rb:E2F {dRb½Rb 
d½Rb:E2F =dt~{k2{k6{(dE2FzdRb)½Rb:E2F 
d½Rbp =dt~{k3zk1zk7zdE2F½Rbp:E2F {dRb½Rbp 
d½Rbp:E2F =dt~{k4zk2{k7{(dE2FzdRb)½Rbp:E2F 
d½Rbpp =dt~k3zk4{dRb½Rbpp 
d½E2F =dt~sE2Fzk4zk6zk7zdRb(½Rb:E2F z½Rbp:E2F ){dE2F½E2F 
d½D =dt~sD½GF zk8{dD½D 
d½D:I =dt~{k8{dD½D:I 
d½E =dt~(sEzsE2F:E½E2F )=(1zsRb:E(½Rb z½Rb:E2F )
2)zk9{dE½E 
d½E:I =dt~{k9{dE½E:I 
d½I =dt~ISF{k5zk8zk9{dI½I 
k1~(k1ad½D zk1adi½D:I )½Rb =(kmz½Rb ){k1b½Rbp =(kmz½Rbp )
k2~(k1ad½D zk1adi½D:I )½Rb:E2F =(kmz½Rb:E2F ){k2b½Rbp:E2F =(kmz½Rbp:E2F )
k3~k3ae½E ½Rbp =(kmz½Rbp ){k3b½Rbpp =(kmz½Rbpp )
k4~k3ae½E ½Rbp:E2F =(kmz½Rbp:E2F )
k5~k5a½E ½I =(kmIz½I )
k6~v1b½Rb:E2F {v1a½Rb ½E2F 
k7~v2b½Rbp:E2F {v2a½Rbp ½E2F 
k8~v3b½D:I {v3a½D ½I 
k9~v4b½E:I {v4a½E ½I 
Dimerization/dissociation kinetic parameters
v1a~2mM
{1 mn{1; v1b~0:5mn {1; v2a~2mn {1; v2b~0:5mn {1; v3a~4mM
{1 mn{1;
v3b~0:2mn {1; v4a~2mM {1 mn{1; v4b~0:4mn {1
Phosphorylation/dephosphorylation kinetic parameters
km~0:1mM; kmI~0:4mM; k1b~1:5mMmn {1; k2b~1:5mMmn {1;
k3b~1:5mMmn {1; k1ad~2mn {1; k1adi~2mn {1; k3ad~4mn {1; k5a~1mn {1
Synthesis/degradation kinetic parameters
sGF~12mMh
{1; kGF~0:2mM; sE2F~3mMh
{1; sRb~3mMh
{1; sD~6h
{1;
sE~12mMh
{1; sE2F:E~3h
{1; sRb:E~0:05mM{2; dD~3h
{1; dE~3h
{1;
dE2F~1:2h
{1; dI~0:6h
{1; dGF~27h
{1; dRb~0:3h
{1
Dynamic equations and parameters associated with the network shown in Figure 1B. There are 12 variables, 31 kinetic parameters and 2 input-dependent control
parameters (IGF and ISF). I: Cip/Kip; D: cyclin D-Cdks; E: cyclin E-Cdks.
doi:10.1371/journal.pone.0035291.t001
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timing of its utmost critical issue, which is cell division.
It is reasonable to postulate that the acquired ability of
mammalian cells to elaborate flexible G1 phases, especially during
developmental processes, takes root in the architecturing of their
G1 regulatory network. We therefore developed a dynamical
modeling approach with the aim to check the role that could play
on G1-phase control two especially striking G1 regulatory
elements: (i) the selective transcriptional repression of cyclin E
by unphosphorylated Rb proteins in very early G1 phase
[14,15,36], which operates to delay the apparition of the cyclin
E-Cdk2 complexes after growth-factor stimulation; (ii) the opposite
effect on cyclin D-Cdk4,6 and cyclin E-Cdk2 of the Cip/Kip
proteins, which, following their accumulation in response to stress
signals [16–18], facilitate the activity of the former complexes
whereas they inhibit the activity of the latter ones. Our simulations
clearly showed that each one of these two G1 regulatory elements
functions to build a sharp frontier between the early and late G1-
phase events and restrict the strong mutual antagonism between
the Cip/Kip proteins and cyclin E-Cdk2 to a short time window
near the G1/S transition. Together, they thus cooperate to endow
mammalian cells with the capacity to finely control their rate of
progression through G1 phase or to sustain fully reversible G1
arrests. Importantly also, our study proposes that the disruption of
these regulatory features through the recruitment of additional
regulatory module can easily convert reversible decisions into
irreversible ones, which may endow mammalian cells with the
ability to control not only the proper timing of their G1-phase
decisions but also whether these would be reversible or
irreversible.
Cip/Kip-mediated, exquisitely-sensitive control of G1-
phase duration in mammalian cells
Our finding that a moderate increment in Cip/Kip proteins
lengthens G1 phase is a priori not surprising and it has already
been documented in several experimental studies [39,40]. Yet, it
has not been realized before that the ability of mammalian cells to
finely tune their G1 length in response to various constant levels of
stress signals and stockpiling of Cip/Kip proteins depends on the
contrasting way how distinct G1-specific cyclin-Cdks are regulated
by the same entities (unphosphorylated Rb proteins and Cip/Kip
proteins), which provides mammalian cells with an extremely
powerful avenue to control their rate of G1-phase progression
according to both the specificity of cell-cycle inhibitory stimuli and
the relative strength of activatory and inhibitory cell-cycle
regulatory signals. This result is not only supported by numerical
experiments but also by dynamical system analysis that predicts an
approximate square-root relationship between the rate of G1
progression and the strength of antimitogenic signals. Although no
quantitative data are available to assess this prediction, this could
nevertheless account for the huge G1-length variability observed
in the course of development in multicellular organisms. In early
embryos, cells can proceed through continuous S-M cycles in a
mere half hour, paced by the oscillations in the activity of the
universal mitosis-specific cyclin-Cdk1 module. As embryogenesis
unfolds, however, a G1 delay is incorporated between M and S
phases, giving time to cells to integrate a wealth of environne-
mental signals whose distribution may be spatially organized and,
accordingly, to commit to divide at appropriate times in
coordination with their neighbours. As a matter of fact, it has
been reported that, in embryonic neural and hematopoietic stem
cells, the decision whether to differentiate or not, correlates with
G1-phase duration [11,12]. Therefore, the ability of mammalian
cells to elaborate exceedingly flexible G1 phases of great variability
in length is crucial to generate tissue diversity and ensure
coordinated tissue development during embryogenesis [11,41].
Our study further suggests that this evolutionary capacity may
originally stem from the emergence, upon the pressure of
environmental constraints, of an early G1-specific cell-cycle
activatory module, namely the cyclin D-Cdk module, distinct
from the universal mitosis-specific cyclin-Cdk module inherited
from unicelled organisms and differently regulated by CKIs.
Figure 3. Features of G1-phase regulation responsible for tunable G1 length and reversible G1 arrest. Three different situations have
been analysed (Top panels): (A) The standard one corresponding to Figure 1 (see Table 1) and two hypothetical ones in which: (B) the Cip/Kip
proteins inhibit the activity of cyclin D-Cdk4,6 (k1adi~0mn{1, k1ad~4mn{1) and (C) unphosphorylated Rb proteins does not repress cyclin E
transcription (sRb:E~0mM{2 that is compensated by reducing sE and sE2F by 70%). Bottom panels: plots depicting the changes in the rate of G1-
phase progression (1=tG1) as a function of ISF, starting from the G0 state (IGF~ISF~0), when G0 exit is triggered by an IGF step equal to one (like in
Fig. 2). Grey (filled and hatched) regions define ISF intensities for which the G1-arrest state is stable. Hatched regions bounded by IC{ and ICz
specify ISF intensities for which G0-arrested cells are able to progress toward S-phase entry following growth factor stimulation but for which G1-
arrested cells fail to return to the cell cycle following stress signal withdrawal.
doi:10.1371/journal.pone.0035291.g003
Flexible Control of Mammalian G1 Progression
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35291Cip/Kip-dependent reversible versus irreversible G1
arrest
It has long been recognized that accumulation of the Cip/Kip
proteins in response to genotoxic and cytotoxic stress signals
eventually leads to G1 arrest by inhibition of the cyclin E-Cdk2
complexes [42]. Actually, many Cip/Kip-inducing signals have
been reported to give rise to reversible G1 arrests, on account of
the fact that, upon stress removal, cell cycle progression could be
restored [43–49]. The rigorous demonstration, however, that such
stimuli are truly able to induce fully reversible G1 arrests would
require to check whether indeed hysteresis does not occur in
experiments in which the stress signal level would gradually be
reduced, which is difficult to achieve in practice. Cip/Kip proteins
have been acknowledged also to contribute to the establishment of
irreversible cell-cycle arrests, for instance in response to differen-
tiation signals or in senescent cells [50]. Our study predicts that,
converting Cip/Kip-mediated G1 arrest from reversible to
irreversible requires additional modules, besides those included
in Figure 1B, to participate in G1-phase regulation. It is
noteworthy that human fibroblasts undergoing replicative senes-
cence in culture typically accumulate a number of markers which
appear to be causally involved in the onset of senescence, including
the p53 tumor suppressor protein and one of its main downstream
effector, p21Cip1, but also p16Ink4a [51,52]. The Ink4a proteins
selectively bind Cdk4,6, blocking the assembly of cyclin D-Cdks
Figure 4. Dynamical mechanisms underlying distinct G1-phase
decisions. (A) Schematic representation of how the ISF signal modifies
the trajectories of G1-phase progression in the state space in the case of
reversible (left panels) and irreversible (right panels) G1-arrest states.
Black circles and white circles indicate a stable equilibrium linked to a
G1-arrest state and an unstable equilibrium, respectively. Half black and
half white circle indicates a saddle-node equilibrium. Left and right
panels correspond to two qualitatively distinct scenarios. In case of limit
cycle trajectories (connecting S to M), panels (a) and (b) would
correspond to a saddle-node bifurcation on invariant cycle and a saddle
homoclinic bifurcation, respectively. (B) Typical asymptotic relationship
between the rate of G1-phase progression (1=tG1) and ISF strength
associated with reversible and irreversible G1-arrest scenarios (see
supporting material).
doi:10.1371/journal.pone.0035291.g004
Figure 5. G1-phase decision variability in presence of fluctu-
ating stress signals. (left panels): standard scenario that gives rise to
a reversible G1-arrest state and corresponding to the scheme depicted
in Figures 1 and 3A. (right panels): scenarios giving rise to irreversible
G1 arrest, combining the schemes depicted in Figures 3B and 3C.
Numerical simulations were performed on several hundreds of cells
subjected to different ISF(t) signals with the same mean vISFw and
the same coefficient of variation of 29%. In fact, ISF switches every 5mn
between uniformly distributed random values. (A,B) Plots of sfate and
stG1, respectively, as a function of vISFw. (C) Time course of ½Cip=Kip 
in 10 cells subjected to an average stress input vISFw indicated by the
dashed line in panels A and B. Asterisks indicate the S-phase entry event
(G1/S transition).
doi:10.1371/journal.pone.0035291.g005
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sequestration of the Cip/Kip proteins in the early stages of G1
phase. According to our study, stress signals favoring the synthesis
and accumulation of p16Ink4a, and p21Cip1-inducing stress
signals could therefore cooperate to induce irreversible G1 arrests.
Interestingly too, it has been reported recently that p27Kip1 fails
to inhibit cyclin D-Cdk4,6 only following tyrosine-phosphorylation
in its N terminal domain [37,38]. Thus, context-dependent
tyrosine-dephosphorylation of p27Kip1 could offer to mammalian
cells a means to shift from a reversible to an irreversible G1-arrest
state.
From cell-cycle models to decision-making theory
A major challenge for science in the twenty-first century is to
develop an integrated understanding of how cells and organisms
survive and reproduce [53]. In this huge task, modeling
approaches that attempt to extract biological design and dynamic
principles will certainly prove of great help. Modeling G1-phase
regulation is especially appealing for theoreticians because G1
phase is a critical period of the cell cycle during which individual
cells make crucial decisions concerning the organism as a whole.
In the search for design principles of G1-phase regulation, the
present modeling study identifies a subset of singularities that
appear to play a paramount role in the temporal control of G1-
phase progression but that were dismissed in previous models. It
should be kept in mind, however, that the core set of regulations
included in our model is embedded within an exceedingly complex
web of signalling and regulatory pathways, which work in concert
to coordinate cell growth, cell division, cell differentiation, stress
management and survival [9]. An important step forward would
be to integrate and reconcile together the multitudinous
theoretical works that have already analysed in detail one or
another aspect of mammalian G1-phase regulation, e.g. the
restriction point [20,22,25,26] or the crosstalk between pathways
controlling various cell fates [24,54,55]. Models of G1-phase
regulation are thus an inexhaustible playgroung to investigate
decision-making properties in terms of reversibility, timing or
stochasticity, which could be extrapolated to other decision-
making systems. In particular, the selection between alternative
decision strategies - reversible, irreversible or hybrid - may be
relevant not only for other cell-cycle arrest decisions [55,56], but
more generally for any biological processes involving sequential
choices, such as during cellular differentiation [57,58], neuronal
spiking [59] or brain cognition [60,61], thereby manifesting
universal principles of biological decision making.
Methods
Mathematical model equations
The molecular processes subsumed under the G1 regulatory
network defined in the first section of the result section and
illustrated in Figure 1B are described by a set of differential
equations according to the standard principles of biochemical
kinetics (Table 1). Thus, the dynamical properties of the
mathematicalmodelarearerepresentedby12differentialequations
describing the time-dependent changes in concentrations of
individual components of the network occuring following their
modification via a variety of biochemical processes including
transcriptional activation/repression, translation, degradation,
phosphorylation, dephosphorylation, association, dissociation. The
phosphorylation/dephosphorylation reactions are supposed to
follow the Michaelis-Menten kinetics [21]. A number of assump-
tions have been made to restrict the quantity of variables: (i) several
proteins (e.g, Cdc25, Myc, p53, Ink4) that are sometimes included
in other G1-phase models [21,25,26,55], are omitted in our own
model because our interest was more specifically focusing on the
interplay between, on the one hand, the cyclin D,E-Cdk activatory
modules and, on the other hand, the Rb/E2F and Cip/Kip
regulatory modules ; (ii) we did not discriminate between the
different members of the Cip/Kip, Rb or E2F protein family, which
are generally supposed to play similar, redundant roles though in
different contexts; (iii) mRNA-regulatory or translocation processes
are also disgarded in our model; (iv) the effect of cell growth is
neglected as well because cell growth is presumed to have a limited
impact on G1-phase progression in somatic cells from multicelled
species. The differential equations used to simulate the G1
regulatory network model were integrated using the second-order
Runge-Kutta scheme with fixed-time step dt~0:005.
Choice of kinetic parameters
Like in most previous models of the cell cycle, the choice of
parameters is mostly arbitrary because of the lack of data
regarding the rate constants of the physiological reactions that
participate in the G1 regulatory network and, also, because we
were interested before all on the phenomenological features of the
network dynamics. Consistently with the literature, the cyclin half-
life is assumed to be shorter than those of the Cip/Kip and E2F
proteins that themselves are assumed to be shorter than the half-
time of Rb proteins. All parameter values are indicated in Table 1
and their possible changes in the course of the study are specified
in the captions. Parameter sensitivity analysis shown in Figure S2
and described in supporting material confirms that the precise
choice of kinetic parameters is not critical for the validity and the
significance of our results as the qualitative properties of the model
are robust to reasonable changes of model parameters.
Supporting Information
Text S1 Dynamic analysis of G1-phase models and G1-
length tunability.
(PDF)
Figure S1 Bifurcation analysis. Bifurcation diagram show-
ing normalized steady state E2F activity as a function of IGF for
ISF~0 (A and C) and as a function of ISF for IGF~0:6 (B and D).
Three G1-phase models depicted in supporting material or in
Figure 3 are shown: the model A (A and B) and the models B and
C (respectively blue and red of C and D). Solid and dashed lines
are associated with stable equilibria and saddle equilibria,
respectively. White circles highlight saddle-node bifurcation points
for which IGF~hGF (destabilization of the G0 state) and
ISF~IC{ (stabilization of the G1-arrest state).
(EPS)
Figure S2 Parameter sensitivity analysis. Plot of hGF, IC{
and ICz as a function of the normalized hysteresis size
(ICz{IC{)=ICz for model A (black crosses), B (red circles) and
C (blue squares) in which all model paramaters are multiplied with
a factor of 1:3 and 0:7.
(EPS)
Figure S3 Asymptotic laws for G1-length tunability. Plot
of 1=tG1 as function of ICz{ISF represented in log-log scale for
the three G1-phase models: (A) For the model A, the relationship
between 1=tG1 and ICz{ISF can be fitted with a square root
function (with a~0:7) for enough small values of ICz{ISF. (B)
For models B and C, the relationship between 1=tG1 and
ICz{ISF can be fitted with the inverse of a logarithm function
(Model B: a~4:2 and b~2:3; Model C: a~9:5 and b~0:5).
(EPS)
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